Manko M, Mohammed M, Ahmed M, Bello A, Egbegbedia P, Abdullahi U
Niger Med J. 2024; 63(4):282-287.
PMID: 38863473
PMC: 11163258.
DOI: 10.60787/NMJ-63-4-74.
Ghazanfar H, Javed N, Qasim A, Sarin Zacharia G, Ghazanfar A, Jyala A
Cancers (Basel). 2024; 16(6).
PMID: 38539547
PMC: 10969013.
DOI: 10.3390/cancers16061214.
Ding L, Ning S, Hu W, Xue Y, Yu S
Oxid Med Cell Longev. 2022; 2022:6595989.
PMID: 36199423
PMC: 9527115.
DOI: 10.1155/2022/6595989.
Abd El-Wahab E, Elgawad W, Abdelaziz M, Mikheal A, Shatat H
Am J Trop Med Hyg. 2022; .
PMID: 35226870
PMC: 9128674.
DOI: 10.4269/ajtmh.21-0918.
Kahraman E, Goker E
Mol Biol Rep. 2022; 49(6):4377-4388.
PMID: 35226260
DOI: 10.1007/s11033-022-07273-9.
The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma.
Li H, Wang Y, Zhang M, Hu J, Li Z, Han B
Transl Cancer Res. 2022; 8(2):532-541.
PMID: 35116785
PMC: 8799116.
DOI: 10.21037/tcr.2019.03.09.
Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing country.
Azit N, Sahran S, Voon Meng L, Subramaniam M, Mokhtar S, Mohammed Nawi A
PLoS One. 2021; 16(12):e0260675.
PMID: 34882716
PMC: 8659343.
DOI: 10.1371/journal.pone.0260675.
Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma.
Pazgan-Simon M, Zuwala-Jagiello J, Kukla M, Grzebyk E, Simon K
Clin Exp Hepatol. 2020; 6(3):235-242.
PMID: 33145430
PMC: 7592085.
DOI: 10.5114/ceh.2020.99517.
Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway.
Fang L, Gao C, Bai R, Wang H, Du S
Cancer Gene Ther. 2020; 28(7-8):875-891.
PMID: 32978504
DOI: 10.1038/s41417-020-0201-z.
XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population.
Naguib M, Helwa M, Soliman M, Abdel-Samiee M, Eljaky A, Hammam O
Asian Pac J Cancer Prev. 2020; 21(4):1031-1037.
PMID: 32334466
PMC: 7445958.
DOI: 10.31557/APJCP.2020.21.4.1031.
Inhibition of cyclinB1 Suppressed the Proliferation, Invasion, and Epithelial Mesenchymal Transition of Hepatocellular Carcinoma Cells and Enhanced the Sensitivity to TRAIL-Induced Apoptosis.
Lv S, Ning H, Li Y, Wang J, Jia Q, Wen H
Onco Targets Ther. 2020; 13:1119-1128.
PMID: 32103981
PMC: 7008233.
DOI: 10.2147/OTT.S225202.
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.
Craciun L, de Wind R, Demetter P, Lucidi V, Bohlok A, Michiels S
BMC Cancer. 2020; 20(1):135.
PMID: 32075608
PMC: 7032008.
DOI: 10.1186/s12885-020-6613-1.
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.
Hassanipour S, Vali M, Gaffari-Fam S, Nikbakht H, Abdzadeh E, Joukar F
EXCLI J. 2020; 19:108-130.
PMID: 32038120
PMC: 7003639.
DOI: 10.17179/excli2019-1842.
High interleukin-8 and/or extracellular signal-regulated kinase 2 expression predicts poor prognosis in patients with hepatocellular carcinoma.
Deng Y, Ning Z, Hu Z, Yu Q, He B, Hu G
Oncol Lett. 2019; 18(5):5215-5224.
PMID: 31612032
PMC: 6781488.
DOI: 10.3892/ol.2019.10907.
Evaluation of Targeted Agents for Advanced and Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis.
Guo T, Liu P, Yang J, Wu P, Chen B, Liu Z
J Cancer. 2019; 10(19):4671-4678.
PMID: 31528232
PMC: 6746130.
DOI: 10.7150/jca.32828.
Association of lncRNA and Gene Polymorphisms with Hepatocellular Carcinoma.
Wu E, Hsieh M, Chiang W, Hsueh K, Yang S, Su S
Int J Environ Res Public Health. 2019; 16(16).
PMID: 31398859
PMC: 6720737.
DOI: 10.3390/ijerph16162833.
Association of lncRNA Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma.
Wu E, Chou Y, Liu Y, Hsueh K, Lee H, Yang S
Genes (Basel). 2019; 10(7).
PMID: 31277475
PMC: 6678962.
DOI: 10.3390/genes10070506.
Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.
Zhao W, Liu X, Yu Z, Xiong Z, Wu J, Sun Y
Mol Genet Genomic Med. 2019; 7(7):e00716.
PMID: 31124313
PMC: 6625101.
DOI: 10.1002/mgg3.716.
Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence?.
Valean S, Chira R, Dumitrascu D
Clujul Med. 2018; 91(4):376-386.
PMID: 30564012
PMC: 6296719.
DOI: 10.15386/cjmed-1067.
MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2.
Cui H, Song R, Wu J, Wang W, Chen X, Yin J
Am J Cancer Res. 2018; 8(3):405-421.
PMID: 29636997
PMC: 5883092.